Insmed To Present at the 42nd Annual J.P. Morgan Healthcare Conference
BRIDGEWATER, N.J., Jan. 2, 2024 /PRNewswire/ — Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that management will present at the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 8, 2024, at 3:00 p.m. PT/6:00 p.m. ET.
Related news for (INSM)
- Insmed to Present Multiple Abstracts at the European Respiratory Society Congress 2025
- Insmed Reports Second-Quarter 2025 Financial Results and Provides Business Update
- Insmed Announces Pricing of $750 Million Public Offering of Common Stock
- Insmed Announces Proposed $650 Million Public Offering of Common Stock
- Insmed Announces Positive Topline Results from Phase 2b Study of Treprostinil Palmitil Inhalation Powder (TPIP) as Once-Daily Therapy in Patients with Pulmonary Arterial Hypertension